UNSPSC 51162310: Acetaminophen/chlorpheniramine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162310 Acetaminophen/chlorpheniramine/phenylephrine, a Commodity code, nominally designates a specific combination cold and allergy medication, but recent state and local procurement activity under this code shows minimal alignment with that narrow product specification. Instead, the two recent opportunities tagged to this code involve procurement of naloxone and drug deactivation systems (Seminole County, Florida) and generic multi-source pharmaceuticals and over-the-counter products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). The mismatch suggests that state and local procurement offices are using this code as a catch-all for pharmaceutical and medical supply acquisitions that do not fit narrower commodity definitions, rather than targeting acetaminophen-chlorpheniramine-phenylephrine formulations specifically. Issuing bodies include county health departments (Seminole County) and state-level cooperative purchasing alliances serving multi-jurisdictional member networks.

Activity is concentrated in Florida and Minnesota as of mid-2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP on January 20, 2026 (due March 26, 2026) to establish multiple manufacturer contracts for generic pharmaceuticals and OTC products distributed across participating state and local facilities, with evaluation weighted heavily on price competitiveness (75 percent) and requiring cGMP certification, Drug Supply Chain Security Act compliance, and relationships with authorized wholesalers. Seminole County, Florida issued an IFB (Solicitation IFB60459723LAS, posted June 30, 2026, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county community health building, with contract duration of two years plus one optional renewal year. The code shows little relevant recent activity narrowly construed to the product combination named in the UNSPSC title.